(Reporter Wang Zhenya of People's Daily Health Client) From one pill last year to 1,000 yuan, to one pill now returning to the original price of 590 yuan, Pianzihuang has experienced a year of decline from prosperity to decline. Pianzihuang's stock price has fallen since July this year, and as of October 30, the stock price fell to 228.23 yuan. The market value dropped from the highest level of 250 billion to 137.8 billion, evaporating 112.2 billion.
"Pianzihuang is not a product that is urgently needed, and it is normal to fluctuate due to market factors." Kang Zhen, deputy director of the National Practical Pharmacist Development Research Center of China Pharmaceutical University, told the People's Daily Health Client reporter.
17 price increase 17 times
According to official website data, since 2005, Pianzihuang has issued a total of 16 announcements of the price adjustment of Pianzihuang in 2017, almost once a year. Domestic prices have also risen from the initial 125 yuan/particle to the current 590 yuan/particle.
In 2021, the price increase of Pianzihuang was not dominated by the official, but was "speculated" by the market. Due to the shortage of raw materials, the supply is in short supply. The price of a piece of scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered scattered sca The stock price of Pianzihuang in 3 months rose by nearly 80%, and its market value soared to 250 billion yuan.
Kang Zhen told the People's Daily Health Client reporter that as a prescription drug, the purchase restrictions and the price has risen sharply in the short term, which is not normal.
PianZaiYong's recent third-quarter report showed that the performance in the third quarter showed a significant decline, with the company's revenue and net profit of 2.193 billion yuan and 738 million yuan respectively, with both revenue and net profit falling, down 3.08% and 17.64% year-on-year respectively. Pianzihuang issued an announcement to respond to the reasons for performance fluctuations, and the company attributed it to the high performance base in the third quarter of 2021.
price returned to normal, and Pianzihuang developed big health products
compared with the same quarter last year, in addition to the decline in performance, Pianzihuang also returned to normal prices.
"The store was indeed closed some time ago, and it just opened on October 22." A staff member of the Beijing Pianzihuang flagship store (Galaxy SOHO store) told the People's Daily Health Client reporter that compared with last year, consumers at the door lined up to buy medicine, there are not many people now, and the price has also dropped to 590 yuan/pill. But now the patients who buy medicine are really needed, but they are just returning to normal. Why did the price of
Pianzihuang fall? "The price has not fallen, it's just a normal price." A staff member of the offline store of Xiamen Pianzihuang told reporters that the price increase was previously due to scalpers' speculation. Later, the company took the initiative to restore the balance of the market supply and demand relationship by expanding and stabilizing the supply and stabilizing the supply. Consumers can buy Pianzihuang at normal prices through official channels. Scalpers are not profitable, and the speculation will naturally stop.
pills Zaihuang's overall performance is greatly affected by the sales of a single variety, which is also a problem faced by many traditional Chinese medicine companies. Kang Zhen told reporters that many traditional Chinese medicine companies are now starting to focus on big health products to increase revenue. The same is true for Pianzihuang, proposing a "one core and two wings" big health development strategy, strengthening the development of cosmetics, daily chemical products, health products, and health foods, to achieve diversified breakthroughs.
PianZaiYong Cosmetics Daily Chemicals sector revenue has been showing an upward trend. From 2017 to 2020, the operating income of cosmetics daily chemicals was RMB 175 million, RMB 274 million, RMB 430 million and RMB 905 million, respectively. In the first half of this year, the daily chemical revenue of cosmetics was 350 million yuan.
